Figure 3

(A) Hematoxylin and eosin (H&E) technique developed in the ventral prostate; (B) BCL-2 immunohistochemistry protein in the ventral prostate; (C) BAX immunohistochemistry protein in the ventral prostate; (D) Immunofluorescence of KI-67 protein in ventral prostate; (E) Epithelium volume (%) of ventral prostate; (F) Connective tissue (%) of prostatic tissue; (G) Lumen (%) in prostate samples; (H) KI-67 (%); Bar = 20 um, 400×magnification and 100×magnification in image A.